CAS RN: 415913-05-2
quinoline-5-sulfonamide
Product Availability
Choose a grade to view its available package options.
5 package records 3 with current stock 1 grade group
Grade
95% (5)
In stock only
Batch No. Package Availability Warehouse Lead Time Inquiry
Batchno.20251014
100mg
In stock
Shanghai Inquiry
Batchno.20250807
100mg / 250mg / 1g / 5g
Out of stock
5-7 business days Inquiry
Batchno.20260613
1g
In stock
Shenzhen, Tianjin, Chengdu Inquiry
Batchno.20251114
250mg
In stock
Shanghai, Tianjin, Wuhan Inquiry
Batchno.20260320
5g
Out of stock
Inquiry
GET A QUOTE
This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.
Pack sizes on record: 1g
Available purity: ≥95%
Inventory rows with stock: 0
Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 415913-05-2
Pack Size
Recorded Purity
Available Qty
Ship From
Inquiry
1g
≥95%
0
Out of Stock
Shanghai
Inquiry
415913-05-2 / quinoline-5-sulfonamide
Standard CAS: 415913-05-2
Multi CAS: No
Basic Information
copy
CAS
415913-05-2 copy
Multi CAS
No copy
Molecular Formula
C9H8N2O2S copy
Molecular Weight
208.240000 copy
Exact Mass
208.030649 copy
InChI
InChI=1S/C9H8N2O2S/c10-14(12,13)9-5-1-4-8-7(9)3-2-6-11-8/h1-6H,(H2,10,12,13) copy
InChIKey
DWHIGANEUNBVPB-UHFFFAOYSA-N copy
Computed Properties
copy
Structural Parameters
Heavy atom count
14 copy
Aromatic heavy atom count
10 copy
Rotatable bonds
1 copy
H-bond acceptors
3 copy
H-bond donors
1 copy
Molar refractivity
53.12 copy
TPSA
73.05 copy
LogP / Solubility
WLOGP
0.88 copy
MLOGP
0.78 copy
XLogP3
1.2 copy
Consensus LogP
0.95 copy
Log S (ESOL)
-2.15 copy
Class (ESOL)
Moderately soluble copy
Log S (Ali)
-1.9 copy
Class (Ali)
Soluble copy
Log S (SILICOS-IT)
-1.87 copy
Class (SILICOS-IT)
Soluble copy
ADME
GI absorption
High copy
BBB permeant
Yes copy
P-gp substrate
No copy
CYP1A2 inhibitor
No copy
CYP2C19 inhibitor
No copy
CYP2C9 inhibitor
No copy
CYP2D6 inhibitor
No copy
CYP3A4 inhibitor
No copy
Log Kp (skin permeation)
-3.36 copy
Drug-likeness / Medicinal Chemistry
Lipinski
Yes copy
Ghose
No copy
Veber
Yes copy
Egan
Yes copy
Muegge
Yes copy
Bioavailability score
0.55 copy
Leadlikeness
No copy
Synthetic Accessibility
1.5 copy